Cite
HARVARD Citation
Ko, B. et al. (n.d.). Metabolic characterization of imatinib-resistant BCR-ABL T315I chronic myeloid leukemia cells indicates down-regulation of glycolytic pathway and low ROS production. Leukemia & lymphoma. 57 (9), pp. 2180-2188. [Online].